Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 20, 2013

View Archived Issues

Quantitative, non-invasive, magnetic resonance imaging of tumor metabolism in vivo

Identification of a novel clinical biomarker for a specific subset of patients with breast cancer

Phase I clinical evaluation of a sporozoite-based vaccine for immunization against malaria

LIDDS reports data from second phase IIa study of Liproca Depot

Researchers highlight the relevance of BAP1 mutations in melanoma

Retrophin to exclusively negotiate development rights for autism and schizophrenia treatment

Retrophin reports RE-024 preclinical results

FDA approves GSK's FluLaval Quadrivalent influenza virus vaccine

Australian government provides grant to Aeras for tuberculosis vaccine

New MGAT2 inhibitors for hypertriglyceridemia presented by Eli Lilly

Taiho Pharmaceutical designs novel agents for urinary incontinence

Selexys commences with SUSTAIN phase II trial

Roche and Genentech disclose new MEKKK4 inhibitors

Actelion synthesizes new chemokine CXCR3 receptor modulators

French authorities grant market access to Pixuvri for aggressive non-Hodgkin's lymphoma

Toyama Chemical Co. presents novel products for HIV infection

Tau Therapeutics collaborator receives grant for glioblastoma reserach

BIND Therapeutics initiates dosing in phase II PSMA-targeting study

GenSpera raises funds for G-202 development

to-BBB to proceed to phase IIa 2B3-101 study

GTx' POWER trials fail to meet primary endpoints

Wanbang Pharma to develop Sirona Biochem's SGLT2 inhibitor in China

FDA approves Trokendi XR launch

Japanese researchers divulge new tubulin polymerization inhibitors

Japanese authorities approve Bayer's Stivarga for GIST

Popular Stories

23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Today's news in brief
BioWorld
BioWorld briefs for June 18, 2025.
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 18, 2025.
EACR 2025: Immune rewiring in cancer orchestrates tumor microenvironment
BioWorld Science
Among the presentations included in the Top Abstracts category at the recently inaugurated Annual Congress of the European Association for Cancer Research (EACR)...